| 注册
首页|期刊导航|临床眼科杂志|经巩膜睫状体光凝术与Ahmed引流阀植入治疗晚期难治性青光眼的疗效对比

经巩膜睫状体光凝术与Ahmed引流阀植入治疗晚期难治性青光眼的疗效对比

徐晋 袁志兰 梁亚

临床眼科杂志2026,Vol.34Issue(1):40-45,6.
临床眼科杂志2026,Vol.34Issue(1):40-45,6.DOI:10.3969/j.issn.1006-8422.2026.01.009

经巩膜睫状体光凝术与Ahmed引流阀植入治疗晚期难治性青光眼的疗效对比

Comparative analysis of efficacy between transscleral cyclophotocoagulation and ahmed glaucoma valve im-plantation in the treatment of advanced refractory glaucoma

徐晋 1袁志兰 2梁亚2

作者信息

  • 1. 215400 江苏太仓,太仓市第一人民医院眼科
  • 2. 210029 南京,南京医科大学第一附属医院 江苏省人民医院眼科
  • 折叠

摘要

Abstract

Objective To assess the clinical efficacy,safety,and cost-effectiveness of transscleral cyclophotoco-agulation(TSCPC)versus ahmed glaucoma valve implantation in patients with advanced refractory glaucoma.Methods Retrospective case analysis.From February 2014 to November 70 patients(72 eyes)with advanced refractory glaucoma were diagnosed and treated in the Ophthalmology Department of Jiangsu Provincial People's Hospital,of whom 36 eyes un-derwent transscleral cyclophotocoagulation(TSCPC)and 36 eyes received ahmed glaucoma valve implantation.The intraocu-lar pressure(IOP)at each follow-up time point before and after the surgery,the ocular pain before and at 6 months after the surgery,the best corrected visual acuity(BCVA),number of anti-glaucoma medications and complications were recorded.Complete success rate of the surgery and conditional success rate of the surgery(6 mmHg≤IOP≤21 mmHg with or without medications)were analyzed.Results IOP and the number of anti-glaucoma medications decreased significantly after the surgery(P<0.05).The IOP in the TSCPC group decreased from(42.3±9.9)mmHg(medications:2.6±0.6 kinds)to(16.4±8.0)mmHg(0.4±0.7),and the IOP in the ahmed valve group decreased from(40.3±7.6)mmHg(2.4±0.7)to(23.0±12.4)mmHg(0.7±0.9).The conditional success rate was 72.2%in the TSCPC group and 66.7%in the ahmed valve group at 6 months postoperatively.The complete success rate was 63.9%in the photocoagulation group and 44.4%in the ahmed valve group(P>0.05).Complications occurred in 2 eyes in the photocoagulation group and 4 eyes in the ahmed valve group.Conclusions Both transscleral cyclophotocoagulation and ahmed glaucoma valve implantation can safely and effectively reduce the IOP and maintain the visual acuity of patients with advanced refractory glaucoma.Transscleral cyclophotocoagu-lation is simpler,safer and more economical.It can more effectively control the IOP,significantly relieve ocular pain,and reduce the variety of medications.

关键词

经巩膜睫状体光凝术/Ahmed引流阀/难治性青光眼/眼压

Key words

Transscleral cyclophotocoagulation/Ahmed glaucoma valve/Refractory glaucoma/Intraocular pres-sure

引用本文复制引用

徐晋,袁志兰,梁亚..经巩膜睫状体光凝术与Ahmed引流阀植入治疗晚期难治性青光眼的疗效对比[J].临床眼科杂志,2026,34(1):40-45,6.

基金项目

国家自然科学基金青年基金项目(82101122) (82101122)

江苏省人民医院"临床能力提升工程"医疗项目(JSPH-MB-2021-3) (JSPH-MB-2021-3)

临床眼科杂志

1006-8422

访问量1
|
下载量0
段落导航相关论文